Here's a look at the latest contest stock action. Mergers and acquisitions played a strong part in the best performers (MedImmune, Baush & Lomb) as well as earnings figures (Angiodynamics). A couple of newer names showed up in the most active list (Ligand and Angiotech) while the widely held stocks stayed the same.
Hey everyone, guest blogger Jeff Mishlove is here with his picks for this last day of the trading week. We'll get right to his thoughts: Wednesday’s picks illustrated the principle (I’ve often emphasized on CNBC’s “How to Win” program) that the short-squeeze strategy is productive of large moves in both directions. Of course, I am not privy to inside information, so if the earnings report is below expectations, we can see a large downward move..